Questions and answers on antithrombotic therapy: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation†

Affiliations

• ¹ ACTION study Group, Institut de Cardiologie, INSERM_UMRS 1166, Pitié-Salpêtrière Hospital (AP-HP), UPMC Paris 6, France.
• ² Division of Cardiology, University Hospital, Geneva, Switzerland [email protected].
• ³ Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital, Basel, Switzerland.
• ⁴ Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
• ⁵ Istituto di Farmacologia, Università Cattolica del Sacro Cuore, Rome, Italy.
• ⁶ The content of this article does not necessarily reflect the opinion of the entire Task Force for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation nor of the Committee for Practice Guidelines of the European Society of Cardiology (ESC).The disclosure forms of all experts involved in the development of these guidelines are available on the ESC website http://www.escardio.org/guidelines ACTION study Group, Institut de Cardiologie, INSERM_UMRS 1166, Pitié-Salpêtrière Hospital (AP-HP), UPMC Paris 6, France Division of Cardiology, University Hospital, Geneva, Switzerland Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital, Basel, Switzerland Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands Istituto di Farmacologia, Università Cattolica del Sacro Cuore, Rome, Italy.